Cargando…

Hepatoblastoma: Transplant Versus Resection Experience in a Latin American Transplant Center

BACKGROUND: Hepatoblastoma is the most common primary malignant liver tumor in children and is usually diagnosed during the first 3 years of life. Overall survival has increased 50% due to chemotherapeutic schemes, expertise surgery centers, and liver transplantation. METHODS: A retrospective collec...

Descripción completa

Detalles Bibliográficos
Autores principales: Caicedo, Luis A., Sabogal, Angie, Serrano, Oscar, Villegas, Jorge I., Botero, Verónica, Agudelo, María T., Lotero, Viviana, Dávalos, Diana, Manzi, Eliana, Aristizabal, Ana M., Gomez, Catalina, Echeverri, Gabriel J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464784/
https://www.ncbi.nlm.nih.gov/pubmed/28620649
http://dx.doi.org/10.1097/TXD.0000000000000685
_version_ 1783242831771467776
author Caicedo, Luis A.
Sabogal, Angie
Serrano, Oscar
Villegas, Jorge I.
Botero, Verónica
Agudelo, María T.
Lotero, Viviana
Dávalos, Diana
Manzi, Eliana
Aristizabal, Ana M.
Gomez, Catalina
Echeverri, Gabriel J.
author_facet Caicedo, Luis A.
Sabogal, Angie
Serrano, Oscar
Villegas, Jorge I.
Botero, Verónica
Agudelo, María T.
Lotero, Viviana
Dávalos, Diana
Manzi, Eliana
Aristizabal, Ana M.
Gomez, Catalina
Echeverri, Gabriel J.
author_sort Caicedo, Luis A.
collection PubMed
description BACKGROUND: Hepatoblastoma is the most common primary malignant liver tumor in children and is usually diagnosed during the first 3 years of life. Overall survival has increased 50% due to chemotherapeutic schemes, expertise surgery centers, and liver transplantation. METHODS: A retrospective collection of data was performed from pediatric patients with diagnosis of hepatoblastoma. Variables included demographic, diagnostic tools and histological classification; chemotherapy and surgical treatment; and outcomes and patient survival. The PRETEXT classification was applied, which included the risk evaluation, and according to the medical criterion in an individualized way, underwent resection or transplant. The morbidity of patients was evaluated by the Clavien-Dindo classification. Statistical analysis was performed according to the distribution of data and the survival analysis was carried out using the Kaplan-Meier method. RESULTS: The patients (n = 16) were divided in a resection group (n = 8) and a transplant group (n = 8). The median age at the time of diagnosis was 13.5 months. The motive for the initial consultation was the discovery of a mass; all patients had high levels of α-fetoprotein and an imaging study. Ten of 16 patients required chemotherapy before the surgical procedure. In the resection group, 5 of 8 patients were classified as Clavien I and 4 of 8 patients of the transplant group were classified as Clavien II. Patient survival at 30 months was 100% in the resection group and 65% in the liver transplantation group. CONCLUSIONS: To our knowledge, this is the first case report of pediatric patients with hepatoblastoma and liver resection or transplant in Colombia and Latin America. Our results are comparable with the series worldwide, showing that resection and transplant increase the survival of the pediatric patients with hepatoblastoma. It is important to advocate for an increase of reporting in the scientific literature in Latin America.
format Online
Article
Text
id pubmed-5464784
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-54647842017-06-15 Hepatoblastoma: Transplant Versus Resection Experience in a Latin American Transplant Center Caicedo, Luis A. Sabogal, Angie Serrano, Oscar Villegas, Jorge I. Botero, Verónica Agudelo, María T. Lotero, Viviana Dávalos, Diana Manzi, Eliana Aristizabal, Ana M. Gomez, Catalina Echeverri, Gabriel J. Transplant Direct Liver Transplantation BACKGROUND: Hepatoblastoma is the most common primary malignant liver tumor in children and is usually diagnosed during the first 3 years of life. Overall survival has increased 50% due to chemotherapeutic schemes, expertise surgery centers, and liver transplantation. METHODS: A retrospective collection of data was performed from pediatric patients with diagnosis of hepatoblastoma. Variables included demographic, diagnostic tools and histological classification; chemotherapy and surgical treatment; and outcomes and patient survival. The PRETEXT classification was applied, which included the risk evaluation, and according to the medical criterion in an individualized way, underwent resection or transplant. The morbidity of patients was evaluated by the Clavien-Dindo classification. Statistical analysis was performed according to the distribution of data and the survival analysis was carried out using the Kaplan-Meier method. RESULTS: The patients (n = 16) were divided in a resection group (n = 8) and a transplant group (n = 8). The median age at the time of diagnosis was 13.5 months. The motive for the initial consultation was the discovery of a mass; all patients had high levels of α-fetoprotein and an imaging study. Ten of 16 patients required chemotherapy before the surgical procedure. In the resection group, 5 of 8 patients were classified as Clavien I and 4 of 8 patients of the transplant group were classified as Clavien II. Patient survival at 30 months was 100% in the resection group and 65% in the liver transplantation group. CONCLUSIONS: To our knowledge, this is the first case report of pediatric patients with hepatoblastoma and liver resection or transplant in Colombia and Latin America. Our results are comparable with the series worldwide, showing that resection and transplant increase the survival of the pediatric patients with hepatoblastoma. It is important to advocate for an increase of reporting in the scientific literature in Latin America. Lippincott Williams & Wilkins 2017-05-25 /pmc/articles/PMC5464784/ /pubmed/28620649 http://dx.doi.org/10.1097/TXD.0000000000000685 Text en Copyright © 2017 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Liver Transplantation
Caicedo, Luis A.
Sabogal, Angie
Serrano, Oscar
Villegas, Jorge I.
Botero, Verónica
Agudelo, María T.
Lotero, Viviana
Dávalos, Diana
Manzi, Eliana
Aristizabal, Ana M.
Gomez, Catalina
Echeverri, Gabriel J.
Hepatoblastoma: Transplant Versus Resection Experience in a Latin American Transplant Center
title Hepatoblastoma: Transplant Versus Resection Experience in a Latin American Transplant Center
title_full Hepatoblastoma: Transplant Versus Resection Experience in a Latin American Transplant Center
title_fullStr Hepatoblastoma: Transplant Versus Resection Experience in a Latin American Transplant Center
title_full_unstemmed Hepatoblastoma: Transplant Versus Resection Experience in a Latin American Transplant Center
title_short Hepatoblastoma: Transplant Versus Resection Experience in a Latin American Transplant Center
title_sort hepatoblastoma: transplant versus resection experience in a latin american transplant center
topic Liver Transplantation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464784/
https://www.ncbi.nlm.nih.gov/pubmed/28620649
http://dx.doi.org/10.1097/TXD.0000000000000685
work_keys_str_mv AT caicedoluisa hepatoblastomatransplantversusresectionexperienceinalatinamericantransplantcenter
AT sabogalangie hepatoblastomatransplantversusresectionexperienceinalatinamericantransplantcenter
AT serranooscar hepatoblastomatransplantversusresectionexperienceinalatinamericantransplantcenter
AT villegasjorgei hepatoblastomatransplantversusresectionexperienceinalatinamericantransplantcenter
AT boteroveronica hepatoblastomatransplantversusresectionexperienceinalatinamericantransplantcenter
AT agudelomariat hepatoblastomatransplantversusresectionexperienceinalatinamericantransplantcenter
AT loteroviviana hepatoblastomatransplantversusresectionexperienceinalatinamericantransplantcenter
AT davalosdiana hepatoblastomatransplantversusresectionexperienceinalatinamericantransplantcenter
AT manzieliana hepatoblastomatransplantversusresectionexperienceinalatinamericantransplantcenter
AT aristizabalanam hepatoblastomatransplantversusresectionexperienceinalatinamericantransplantcenter
AT gomezcatalina hepatoblastomatransplantversusresectionexperienceinalatinamericantransplantcenter
AT echeverrigabrielj hepatoblastomatransplantversusresectionexperienceinalatinamericantransplantcenter